Targeting peripheral nerves: a method for therapeutic modulation of inflammatory disease with non-invasive temporal interference
The project aims to develop a non-invasive, patch-based nerve stimulator using Temporal Interference to precisely target inflammation-regulating nerves, enhancing treatment for inflammatory diseases.
Projectdetails
Introduction
Excessive inflammation underlies the development of inflammatory diseases, e.g. Rheumatoid arthritis, Crohn's Disease, inflammatory bowel disease, and cardiovascular disease - the most common cause of death in the world.
Molecular Mechanisms
Human physiology is controlled by defined molecular mechanisms, commonly regulated by specific target nerves and their associated reflexes which optimize function, for example, molecular mechanisms regulating inflammation.
Bioelectronic Medicine
Harnessing the power of the inherent nerve reflexes, which are evolutionarily adapted to regulate specific molecular mechanisms, holds promise to overcome many of the drawbacks intrinsic to current drug therapies. This approach, designated bioelectronic medicine, presents a radically improved way to both treat and better understand disease with increased adaptability and precision.
Role of the Vagus Nerve
The vagus nerve, as shown by the team in this project and other groups, plays a key role in regulating key pro-inflammatory cytokines, pro-resolving mediators, and controls inflammation.
Challenges of Current Methods
However, specific targeting of the vagus nerve has required neurosurgical implantation of a pacemaker-like stimulator device with a control unit, a connecting cable, and an electrode implanted at depth. The requirement for highly specialized surgery significantly limits the usefulness and possibilities for implementation of nerve stimulation in the treatment of inflammation.
Risks of Surgery
Surgery and device implantation also carry risks for permanent tissue damage, local inflammation, infection, and other potentially serious complications.
Project Goals
TREATMENT will generate a precise, non-invasive nerve stimulator that uses Temporal Interference in an ultra-thin form factor (enabling patch-based applications) that will:
- Target one nerve of interest and avoid off-target stimulation.
- Avoid surgery.
- Simplify effective use.
- Enable bioelectronic medicine.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 150.000 |
Totale projectbegroting | € 150.000 |
Tijdlijn
Startdatum | 1-4-2023 |
Einddatum | 30-9-2024 |
Subsidiejaar | 2023 |
Partners & Locaties
Projectpartners
- FAKULTNI NEMOCNICE U SV ANNY V BRNEpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Rediscovering the Wanderer: restoration of sympathico-vagal disbalance in irritable bowel syndrome by neuromodulation – a novel therapeutic conceptThis project aims to restore vagal tone in IBS patients through transcutaneous electrical vagus nerve stimulation, potentially transforming treatment by identifying a neurosignature for personalized therapy. | ERC Starting... | € 1.500.000 | 2023 | Details |
Wireless magnetothermal entero-modulationThis project aims to develop a biocompatible magnetic gel for remote activation of intestinal tissue to modulate calcium signaling and neuropeptide release, addressing GI disorders non-invasively. | ERC Starting... | € 1.500.000 | 2024 | Details |
Revolutionizing diabetes management by combining in silico models and AI control for vagus neuroprosthesesThe project aims to develop a personalized Vagus Nerve Stimulation neuroprosthesis for automated glucose regulation in diabetics, utilizing AI to optimize stimulation and minimize side effects. | ERC Consolid... | € 1.999.201 | 2025 | Details |
Network Synergies in Tissue Homeostasis and Stromal Prevention of Inflammatory Disease.This project aims to uncover the mechanisms of tissue homeostasis and stromal biology to prevent inflammation onset, using advanced bioimaging and computational techniques for therapeutic advancements. | ERC Starting... | € 1.499.514 | 2022 | Details |
PERSONALIZED NON-INVASIVE NEUROMODULATION IN PAINPersoNINpain aims to personalize chronic pain treatment by using brain connectivity metrics to optimize non-invasive neuromodulation techniques like rTMS for individual patients. | ERC Consolid... | € 1.618.278 | 2023 | Details |
Rediscovering the Wanderer: restoration of sympathico-vagal disbalance in irritable bowel syndrome by neuromodulation – a novel therapeutic concept
This project aims to restore vagal tone in IBS patients through transcutaneous electrical vagus nerve stimulation, potentially transforming treatment by identifying a neurosignature for personalized therapy.
Wireless magnetothermal entero-modulation
This project aims to develop a biocompatible magnetic gel for remote activation of intestinal tissue to modulate calcium signaling and neuropeptide release, addressing GI disorders non-invasively.
Revolutionizing diabetes management by combining in silico models and AI control for vagus neuroprostheses
The project aims to develop a personalized Vagus Nerve Stimulation neuroprosthesis for automated glucose regulation in diabetics, utilizing AI to optimize stimulation and minimize side effects.
Network Synergies in Tissue Homeostasis and Stromal Prevention of Inflammatory Disease.
This project aims to uncover the mechanisms of tissue homeostasis and stromal biology to prevent inflammation onset, using advanced bioimaging and computational techniques for therapeutic advancements.
PERSONALIZED NON-INVASIVE NEUROMODULATION IN PAIN
PersoNINpain aims to personalize chronic pain treatment by using brain connectivity metrics to optimize non-invasive neuromodulation techniques like rTMS for individual patients.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
LUMINESCENT IMPLANTS AS PORTS FOR LIGHT-BASED THERAPIESThe project aims to develop PhotoTheraPorts for localized light delivery to enhance anti-inflammatory and neuroinhibitory drug efficacy, improving treatment precision for neuropathic pain and epilepsy. | EIC Pathfinder | € 2.999.840 | 2024 | Details |
Advanced Intelligent stimulation device: HAND movement restorationThe AI-HAND project aims to develop an advanced ASIC-based implanted device with self-adapting electrodes to restore hand movements in quadriplegic patients through innovative nerve stimulation techniques. | EIC Pathfinder | € 2.999.834 | 2023 | Details |
MagnetoElectric and Ultrasonic Technology for Advanced BRAIN modulationMETA-BRAIN aims to develop non-invasive, precise control of brain activity using magnetoelectric nanoarchitectures and ultrasonic technologies, enhancing treatment for neurological disorders. | EIC Pathfinder | € 2.987.655 | 2024 | Details |
NAO.VNS: A New Personalized Neural Stimulation Therapy For Drug-resistant EpilepsyNAO.VNS is an innovative implantable vagus nerve stimulator using optical fibers to enhance treatment for drug-resistant epilepsy, enabling personalized therapy and remote monitoring, with market approval expected by 2028. | EIC Accelerator | € 2.499.000 | 2023 | Details |
Brain Interchange ONE SR—the implantable neuromodulation technology for stroke rehabilitationCorTec aims to develop innovative implantable technology for stroke rehabilitation, enabling new therapies and devices while targeting market approval and $250M in sales by 2030. | EIC Accelerator | € 2.500.000 | 2022 | Details |
LUMINESCENT IMPLANTS AS PORTS FOR LIGHT-BASED THERAPIES
The project aims to develop PhotoTheraPorts for localized light delivery to enhance anti-inflammatory and neuroinhibitory drug efficacy, improving treatment precision for neuropathic pain and epilepsy.
Advanced Intelligent stimulation device: HAND movement restoration
The AI-HAND project aims to develop an advanced ASIC-based implanted device with self-adapting electrodes to restore hand movements in quadriplegic patients through innovative nerve stimulation techniques.
MagnetoElectric and Ultrasonic Technology for Advanced BRAIN modulation
META-BRAIN aims to develop non-invasive, precise control of brain activity using magnetoelectric nanoarchitectures and ultrasonic technologies, enhancing treatment for neurological disorders.
NAO.VNS: A New Personalized Neural Stimulation Therapy For Drug-resistant Epilepsy
NAO.VNS is an innovative implantable vagus nerve stimulator using optical fibers to enhance treatment for drug-resistant epilepsy, enabling personalized therapy and remote monitoring, with market approval expected by 2028.
Brain Interchange ONE SR—the implantable neuromodulation technology for stroke rehabilitation
CorTec aims to develop innovative implantable technology for stroke rehabilitation, enabling new therapies and devices while targeting market approval and $250M in sales by 2030.